Genetic tests that detect mutations in the B R C A 1 and B R...

Genetic tests that detect mutations in the $B R C A 1$ and $B R C A 2$ oncogenes are widely available. These tests reveal a number of mutations in these genes-mutations that have been linked to familial breast cancer. Assume that a young woman in a suspected breast cancer family takes the $B R C A 1$ and $B R C A 2$ genetic tests and receives negative results. That is, she does not test positive for the mutant alleles of $B R C A I$ or $B R C A 2$. Can she consider herself free of risk for breast cancer?

Key Concepts

Multifactorial Inheritance

Many common diseases, including breast cancer, are influenced by multiple genetic and environmental factors. Multifactorial inheritance implies that even if major genetic risk factors are not present, an individual can still be at risk due to the combined effects of other genetic variants, lifestyle choices, and environmental exposures. Therefore, the absence of a known mutation does not guarantee immunity from the disease.

Familial versus Sporadic Disease

In the context of diseases like breast cancer, there is a distinction between familial (inherited) cases and sporadic cases that arise without a clear hereditary component. While tests may identify mutations associated with familial cases, sporadic cases may result from other genetic or environmental influences. Thus, a negative genetic test result does not fully exclude the possibility of developing the disease if other risk factors are present.

Genetic Testing Limitations

Genetic tests generally target a subset of known mutations and may miss rare or novel mutations that contribute to disease risk. A negative result means that the tested mutations were not detected, but it does not rule out other genetic alterations or mechanisms that could predispose an individual to disease. This underscores that a negative result on a specific genetic test is not equivalent to a complete lack of risk.

Transcript

Please give Ace some feedback